Lars Berger and Eric Linvill discuss the rapid growth of the cardiometabolic disease space in light of the global obesity epidemic and how advanced autoinjector and injection pen technologies, such as SHL Medicals Molly platform, will be necessary to meet the challenges presented by this disease area
Among the most exciting developments is the exploration of cagrilintide dosage with tirzepatide a combination that represents the cutting edge of multi-pathway metabolic intervention
Built for patients using GLP-1 medications, Pivot bridges the gap between prescription and daily adherence, delivering dose tracking, habit logging, and personalized insights that keep users consistent, informed, and motivated
Direct supplementation risks disrupting the body's innate GH rhythm, potentially resulting in side effects like joint pain, muscle aches, or even more severe conditions like diabetes